Celon Pharma S.A.

Celon Pharma S.A., founded in 2002 in Łomianki, Poland and listed on the Warsaw Stock Exchange, is an integrated pharma company conducting R&D and manufacturing for oncology, neurological diseases, diabetes and metabolic disorders. 568 employees, ~USD 348M market cap (2026). Completed 6 data readouts and 11 clinical trials in 5 years. Portfolio includes tablets (Aromek, Ketrel, Lazivir) and inhalation powder (Salmex). EU GMP certified.